S
PLXP

SignatureFD’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

SignatureFD’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-67
Closed – – 3446
2022
Q3 		$0 Hold
67
– – ﹤0.01% 3435
2022
Q2 		$0 Hold
67
– – ﹤0.01% 3423
2022
Q1 		$0 Buy
+67
New +$367 ﹤0.01% 3384
2021
Q4 		– Sell
-600
Closed -$12K – 3335
2021
Q3 		$12K Buy
+600
New +$10.5K ﹤0.01% 1999

Other funds holding PLXP

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
SGCA
Steel Grove Capital Advisors Memphis, Tennessee $949M AUM 23.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UOTTAIMCU
University of Texas/Texas AM Investment Management Co (UTIMCO) Austin, Texas $687M AUM 21.33% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

SignatureFD's PLXP Position: Q4 2022 in Review

SignatureFD sold out of PLx Pharma Inc. Common Stock (PLXP) in Q4 2022, closing a stake of 67 shares.

SignatureFD first reported a position in PLXP in Q3 2021 and held it in 4 quarters. The position peaked at $12K in Q3 2021. 41 funds tracked by Wall St. Rank hold PLXP as of Q4 2022.

  • SignatureFD reported no remaining PLx Pharma Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • SignatureFD sold 67 PLx Pharma Inc. Common Stock shares in Q4 2022.
  • SignatureFD first reported a position in PLx Pharma Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • SignatureFD's PLx Pharma Inc. Common Stock position peaked at $12K in Q3 2021.
  • 41 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2022.

Based on SignatureFD's 13F filing for Q4 2022, filed 30 Jan 2023.